Effect of combination treatment on lung volumes and exercise endurance time in COPD

Respiratory Medicine

Volumn 106, Issue 10, 2012, Pages 1413-1420

  Magnussen, Helgo ^a   Paggiaro, Pierluigi ^b   Schmidt, Hendrik ^c   Kesten, Steven ^d   Metzdorf, Norbert ^c   Maltais, Franois ^e  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Exercise endurance; Fluticasone; Lung hyperinflation; Salmeterol; Tiotropium

Indexed keywords

FLUTICASONE; SALMETEROL; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DYSPNEA; ENDURANCE TRAINING; EXERCISE ENDURANCE TIME; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCORING SYSTEM; THORAX VOLUME; TIME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ALBUTEROL; ANDROSTADIENES; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SCOPOLAMINE DERIVATIVES;

EID: 84865223423     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.05.011     Document Type: Article

References (27)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: updated December 2011. Global Initiative for Chronic Obstructive Lung Disease 2011 www.goldcopd.org
2. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, S. Menjoge, M. Decramer UPLIFT Study Investigators A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
3. D. Mahler, P. Wire, D. Horstman, C.N. Chang, J. Yates, T. Fischer, and T. Shah Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 1084 1091 (Pubitemid 35178706)
4. J.A. van Noord, J.L. Aumann, E. Janssens, J. Verhaert, J.J. Smeets, A. Mueller, and P.J. Cornelissen Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD Chest 129 2006 509 517
5. J.A. van Noord, J.L. Aumann, E. Janssens, J.J. Smeets, J. Verhaert, B. Disse, A. Mueller, and P.J. Cornelissen Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD Eur Respir J 26 2005 214 222 (Pubitemid 41079064)
6. P.M.A. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, P.W. Jones, J.C. Yates, J. Vestbo TORCH Investigators Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789 (Pubitemid 46294610)
7. K. Rabe, W. Timmer, A. Sagkriotis, and K. Viel Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD Chest 134 2008 255 262
8. ATS/ACCP statement on cardiopulmonary exercise testing Am J Respir Crit Care Med 167 2003 211 277
9. American Thoracic Society Standardization of spirometry - 1994 update Am J Respir Crit Care Med 152 1995 1107 1136
10. A.L. Coates, R. Peslin, D. Rodenstein, and J. Stocks Measurement of lung volumes by plethysmography Eur Respir J 10 1997 1415 1427 (Pubitemid 27278270)
11. D.E. O'Donnell, T. Fluege, F. Gerken, A. Hamilton, K. Webb, B. Aguilaniu, B. Make, and H. Magnussen Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur Respir J 23 2004 832 840 (Pubitemid 38807355)
12. F. Maltais, A. Hamilton, D. Marciniuk, P. Hernandez, F.C. Sciurba, K. Richter, S. Kesten, and D. O'Donnell Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD Chest 128 2005 1168 1178 (Pubitemid 41324392)
13. G. Borg Psychophysical basis of perceived exertion Med Sci Sports Exerc 14 1982 377 381
14. B. Aguilaniu Impact of bronchodilator therapy on exercise tolerance in COPD Int J Chron Obstruct Pulmon Dis 5 2010 57 71
15. J.A. van Noord, J.L. Aumann, E. Janssens, J.J. Smeets, J. Zaagsma, A. Mueller, and P.J. Cornelissen Combining tiotropium and salmeterol in COPD: effects on airflow obstruction and symptoms Respir Med 104 2010 995 1004
16. H. Worth, K. Förster, G. Eriksson, U. Nihlén, S. Peterson, and M. Magnussen Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD Respir Med 104 2010 1450 1459
17. D. Tashkin, and S. Kesten Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses Chest 123 2003 1441 1449 (Pubitemid 36549761)
18. M. Cazzola on behalf of the American Thoracic Society/European Respiratory Society Task Force on outcomes of COPD Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur Respir J 31 2008 416 468
19. R. Casaburi Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions COPD 2 2005 131 136 (Pubitemid 40776233)
20. L. Puente-Maestu, F. Villar, J. de Miguel, W.W. Stringer, P. Sanz, M.L. Sanz, J.G. de Pedro, and Y. Martínez-Abad Clinical relevance of constant power exercise duration changes in COPD Eur Respir J 34 2009 340 345
21. D. O'Donnell Ventilatory limitations in chronic obstructive pulmonary disease Med Sci Sports Exerc 33 2001 S647 S655
22. D. Deschênes, V. Pepin, D. Saey, P. LeBlanc, and F. Maltais Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease J Cardiopulm Rehabil Prev 28 2008 208 214
23. R. Casaburi, D. Kukafka, C.B. Cooper, T.J. Witek, and S. Kesten Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD Chest 127 2005 809 817 (Pubitemid 40775509)
24. V. Pepin, D. Saey, F. Whittom, P. LeBlanc, and F. Maltais Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 172 2005 1517 1522 (Pubitemid 43076539)
25. X. Zhang, L. Waterman, J. Ward, J. Baird, and D. Mahler Advantages of endurance treadmill walking compared with cycling to assess bronchodilator therapy Chest 137 2010 1354 1361
26. J. Murray, L. Waterman, J. Ward, J. Baird, and D. Mahler Perceptual and physiologic responses during treadmill and cycle exercise in patients with COPD Chest 135 2009 384 390
27. S. Kesten, B. Celli, M. Decramer, I. Leimer, and D. Tashkin Tiotropium HandiHaler in the treatment of COPD: a review of safety Int J COPD 4 2009 397 409